跳至主要内容
临床试验/CTRI/2015/11/006345
CTRI/2015/11/006345尚未招募3 期

Efficacy of short prednisolone treatment for relapse in children with steroid sensitive nephrotic syndrome: A randomised controlled study

ICMR0 个研究点目标入组 114 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
114

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients diagnosed with steroid sensitive nephrotic syndrome
  • 2. Currently in relapse
  • 3. Those who give written informed consent

排除标准

  • 1. Patients diagnosed with steroid resistant Nephrotic Syndrome
  • 2. Patients with frequent relapses (defined as 2 or more relapses in 6 months or >3 in 12 months) or steroid dependence (defined as 2 consecutive relapses on alternate day therapy or within 2 weeks of discontinuation of therapy)
  • 3. Known secondary cause (e.g. Hepatitis B, SLE, HSP)
  • 4. Patients on alternate regimens with levamisole/cyclophospahmide/mycophenolate mofetil/azathioprine/rituximab
  • 5. Patients who have not recieved atleast 4 weeks of daily steroids at 2 mg/kg followed by 4 weeks of 1.5 mg/kg alternate day steroids during initial episode

研究者

发起方
ICMR

相似试验